• Silence Therapeutics will present Phase 2 divesiran data in polycythemia vera at the American Society of Hematology annual meeting.
• The meeting runs December 12-15, 2026, in New Orleans.
• Marina Kremyanskaya will deliver the oral presentation on December 14, 2026, from 3:30-3:45 p.m. CT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104792260) on November 04, 2026, and is solely responsible for the information contained therein.